SunLink Health Systems
About: SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
Employees: 1,851
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0.03% less ownership
Funds ownership: 13.47% [Q2] → 13.43% (-0.03%) [Q3]
0% less capital invested
Capital invested by funds: $757K [Q2] → $756K (-$1.68K) [Q3]
8% less funds holding
Funds holding: 13 [Q2] → 12 (-1) [Q3]
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Research analyst outlook
We haven’t received any recent analyst ratings for SSY.
Financial journalist opinion
Neutral
Business Wire
1 month ago
SunLink Health Systems, Inc. Announces Fiscal 2025 First Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2024 compared to a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for the first fiscal quarter ended September 30, 2023. During the quarter ended September 30, 2024, the Company sold non-core assets for cash totaling $1,465,0.
Neutral
Business Wire
2 months ago
SunLink Health Systems, Inc. Announces Sale of Trace Regional Hospital Real Estate
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., and an affiliate, have completed the sale of the hospital building and related real estate of its formerly operated Trace Regional Hospital in Houston, Mississippi for approximately $2,000,000. The company said the net proceeds of approximately $1,932,000 will be retained for working capital and general corporate purposes. The company exp.
Neutral
Business Wire
2 months ago
SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth fiscal quarter ended June 30, 2024 compared to a loss from continuing operations of $1,021,000 (or a loss of $0.15 per fully diluted share) for the fourth fiscal quarter ended June 30, 2023. Earnings from discontinued operations were $4,940,000 (or earnings of $0.70 per fully diluted share) for the f.
Neutral
Business Wire
6 months ago
SunLink Health Systems, Inc. Announces Sale of Trace Extended Care & Rehab
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Extended Care & Rehab senior care facility and related real estate in Houston, Mississippi for approximately $7,100,000. The company said the net proceeds of approximately $6,500,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax gain.
Neutral
Business Wire
7 months ago
SunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for its third fiscal quarter ended March 31, 2024 compared to a loss from continuing operations of $453,000 (or a loss of $0.06 per fully diluted share) for the third fiscal quarter ended March 31, 2023. Net loss for the quarter ended March 31, 2024 was $1,396,000 (or a loss of $0.20 per fully diluted share) compar.
Neutral
Business Wire
10 months ago
SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing operations of $2,277,000 (or $0.32 per fully diluted share) for the second fiscal quarter ended December 31, 2022. Net loss for the quarter ended December 31, 2023 was $3,075,000 (or a loss of $0.44 per fully diluted share) c.
Neutral
Business Wire
10 months ago
Sunlink Health Systems' Subsidiary Reaches Revised Agreements for the Sale of Trace Regional Medical Center and Clinics
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its indirect subsidiary, Southern Health Corporation of Houston, Inc. (“Southern”), has reached a revised agreement for the sale of Trace Regional Hospital and three (3) patient clinics in Chickasaw County, MS, (“Trace”) to Progressive Health of Houston, LLC (“Progressive”). Southern sold certain personal and intangible property to Progressive for $500,000 pursuant to an asset purchase agreement, e.
Neutral
Business Wire
1 year ago
SunLink Health Systems, Inc. and Progressive Health Group, LLC, Agree to Extend the Closing Date of Their Previously-Announced Sale of Trace Regional Medical Center
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) today announced that SunLink and Progressive Health Group, LLC (“Progressive”) have amended their previously-announced agreement for the sale by SunLink's subsidiary, Crown Healthcare Investments, LLC, of Trace Regional Medical Center in Houston, Mississippi, to Progressive to, among other things, extend the closing date until January 31, 2024, on substantially the same price and terms previously announced.
Neutral
Business Wire
1 year ago
SunLink Health Systems, Inc. Announces Fiscal 2024 First Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2023 compared to a loss from continuing operations of $605,000 (or a loss of $0.09 per fully diluted share) for the first fiscal quarter ended September 30, 2022. On November 10, 2023, the Company's subsidiary, Crown Healthcare Investments, LLC, signed an agreement w.
Charts implemented using Lightweight Charts™